GABA Production

This marker evaluates the genetic capacity of your microbiome to synthesize GABA (Gamma-Aminobutyric Acid), the main inhibitory and "relaxing" neurotransmitter of the nervous system. The gut-brain connection is bidirectional, and optimal GABA production by your bacteria is a key factor in modulating stress, improving sleep quality, and reducing hypersensitivity or intestinal spasms.

Think of GABA as the "brake pedal" of your nervous system. When you're stressed, your body accelerates; GABA is the molecule responsible for slowing down, inducing calm and relaxation.

Although the brain produces its own GABA, we now know that the gut is one of the body's largest neurotransmitter factories. Certain families of bacteria have the ability to take glutamate (an amino acid present in many foods) and transform it into GABA. Although this bacterial GABA does not easily cross the blood-brain barrier to reach the physical brain, it interacts directly with the Enteric Nervous System (the millions of neurons that line your gut) and sends powerful calming signals to the brain via the vagus nerve.

The ability of your ecosystem to produce this neurotransmitter has a direct impact on the so-called "Gut-Brain Axis":

• Stress and Anxiety Management: Low levels of GABA-producing bacteria have been correlated in multiple clinical studies with a greater predisposition to anxiety and depressive moods.
• Sleep Quality: As a key neurotransmitter for the relaxation of the central nervous system, adequate nocturnal production in the gut favors the transition to deep sleep stages.
• Irritable Bowel Syndrome (IBS) and Pain: In the digestive tract, GABA acts as a local muscle relaxant. Good production helps prevent painful spasms, cramps, and reduces visceral hypersensitivity (the feeling of exaggerated pain from normal gas), classic symptoms of IBS.

The evaluation of GABA production is not performed by measuring the molecule in feces (as it is highly volatile and rapidly consumed), but by quantifying the functional potential of the microbiome.

Using Shotgun metagenomic sequencing, our bioinformatics pipeline maps the genes present in your sample against metabolic pathway databases (such as KEGG or MetaCyc). Specifically, we quantify the abundance of genes encoding the enzyme glutamate decarboxylase (GAD) and its associated pathways.

This analysis allows us to determine if you have a sufficient critical mass of neuroactive bacterial genera. The main producers of GABA in the human ecosystem include species within the genera Bacteroides, Parabacteroides, as well as specific strains of Bifidobacterium and Lactobacillus. Low potential suggests a vulnerability in the gut-brain axis that can be addressed through targeted dietary interventions (increasing precursors like glutamic acid) and neuromodulatory probiotics (psychobiotics).